{
    "id": 29058,
    "fullName": "MAST1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "MAST1 over exp indicates an over expression of the Mast1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 22983,
        "geneSymbol": "MAST1",
        "terms": [
            "MAST1",
            "MCCCHCM",
            "SAST"
        ]
    },
    "variant": "over exp",
    "createDate": "12/05/2018",
    "updateDate": "12/05/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15368,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Lestaurtinib (CEP-701) resensitized ovarian cancer cells overexpressing wild-type MAST1 to Platinol (cisplatin) in culture (PMID: 30033091).",
            "molecularProfile": {
                "id": 30988,
                "profileName": "MAST1 over exp"
            },
            "therapy": {
                "id": 7590,
                "therapyName": "Cisplatin + Lestaurtinib",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 13112,
                    "pubMedId": 30033091,
                    "title": "MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30033091"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15367,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of wild-type MAST1 conferred resistance to Platinol (cisplatin) in an ovarian cancer cell line in culture (PMID: 30033091).",
            "molecularProfile": {
                "id": 30988,
                "profileName": "MAST1 over exp"
            },
            "therapy": {
                "id": 700,
                "therapyName": "Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 13112,
                    "pubMedId": 30033091,
                    "title": "MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30033091"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15369,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Lestaurtinib (CEP-701) resensitized lung cancer cells overexpressing wild-type MAST1 to Platinol (cisplatin) in culture (PMID: 30033091).",
            "molecularProfile": {
                "id": 30988,
                "profileName": "MAST1 over exp"
            },
            "therapy": {
                "id": 7590,
                "therapyName": "Cisplatin + Lestaurtinib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 13112,
                    "pubMedId": 30033091,
                    "title": "MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30033091"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15366,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of wild-type MAST1 conferred resistance to Platinol (cisplatin) in a lung cancer cell line in culture (PMID: 30033091).",
            "molecularProfile": {
                "id": 30988,
                "profileName": "MAST1 over exp"
            },
            "therapy": {
                "id": 700,
                "therapyName": "Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 13112,
                    "pubMedId": 30033091,
                    "title": "MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30033091"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30988,
            "profileName": "MAST1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}